Inborn Errors Working Party (IEWP)
Type d'étude:
Numéro de l'étude:
Type de traitement à base de cellules souches:
Maladies:
Titre court:
Objectif principal:
Principaux critères d'inclusion:
Inclusion criteria: only patients with a molecular diagnosis of IFNGR1/2 deficiency (including both complete and partial defects) AND treated with HSCT (including those patients who died during the procedure) will be eligible
Pays:
Investigateur principal:
Peter Olbrich
Coordinateur EBMT de l'étude:
Sheree Hazelaar & Henric-Jan Blok
E-mail du coordinateur de l'étude:
iewpebmt@lumc.nl